Susquehanna International Group, LLP Lyra Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 217,567 shares of LYRA stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

217,567

Previous 103,430 110.35%

Holding current value

$1.8 Million

Previous $21,000 33.33%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.13 - $0.22 $14,837 - $25,110	114,137 Added 110.35%	217,567 $28,000
Q4 2024 Feb 14, 2025	BUY	$0.17 - $0.28 $15,387 - $25,344	90,517 Added 700.98%	103,430 $21,000
Q3 2024 Nov 14, 2024	SELL	$0.24 - $0.34 $5,339 - $7,563	-22,247 Reduced 63.27%	12,913 $3,000
Q2 2024 Aug 15, 2024	SELL	$0.26 - $6.25 $80,122 - $1.93 Million	-308,162 Reduced 89.76%	35,160 $9,000
Q1 2024 May 07, 2024	BUY	$4.55 - $6.53 $381,772 - $547,906	83,906 Added 32.34%	343,322 $2.14 Million
Q4 2023 Feb 14, 2024	BUY	$2.82 - $5.24 $272,287 - $505,953	96,556 Added 59.29%	259,416 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $445,376 - $724,680	150,975 Added 1270.3%	162,860 $636,000
Q2 2023 Aug 11, 2023	BUY	$1.98 - $4.33 $23,532 - $51,462	11,885 New	11,885 $48,000
Q4 2022 Feb 14, 2023	SELL	$2.44 - $5.42 $19,461 - $43,229	-7,976 Reduced 37.0%	13,582 $42,000
Q3 2022 Nov 14, 2022	BUY	$4.95 - $6.6 $106,712 - $142,282	21,558 New	21,558 $108,000
Q1 2022 May 16, 2022	SELL	$3.5 - $5.36 $39,200 - $60,032	-11,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.22 - $9.41 $19,812 - $44,179	-4,695 Reduced 29.54%	11,200 $49,000
Q3 2021 Nov 15, 2021	SELL	$6.06 - $9.43 $34,142 - $53,128	-5,634 Reduced 26.17%	15,895 $145,000
Q2 2021 Aug 11, 2021	BUY	$6.91 - $12.59 $148,765 - $271,050	21,529 New	21,529 $173,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

25M

Call Options Held

56.6K

Put Options Held

33.9K

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $264M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Lyra Therapeutics, Inc. Transaction History